Carlos Manuel de Castro, MD

Publications

Pabon, Cindy M., Zhiguo Li, Therese Hennig, Carlos de Castro, Jadee L. Neff, Mitchell E. Horwitz, Thomas W. LeBlanc, et al. “Morphologic leukemia-free state in acute myeloid leukemia is sufficient for successful allogeneic hematopoietic stem cell transplant.” Blood Cancer J 11, no. 5 (May 16, 2021): 92. https://doi.org/10.1038/s41408-021-00481-9.

PMID
33994546
Full Text

De latour, Regis Peffault, Carlos M. De Castro, Jeffrey Szer, Kensuke Usuki, Peter Hillmen, Morag Griffin, Mohamed Hamdani, Temitayo Ajayi, Hisakazu Nishimori, and Ilene C. Weitz. “"Superiority of Pegcetacoplan Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria, Regardless of Prior Transfusion Requirement: Analysis at 16-weeks of PEGASUS Phase 3 Randomized Trial".” In British Journal of Haematology, 193:189–90, 2021.

Scholars@Duke

Roeth, Alexander, Britta Hoechsmann, Morag Griffin, Carlos M. De Castro, Jeffrey Szer, Kensuke Usuki, Juliette Soret, et al. “Effect of Pegcetacoplan on Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria from the Pegasus Phase 3 Trial Comparing Pegcetacoplan to Eculizumab.” In British Journal of Haematology, 193:198–99, 2021.

Scholars@Duke

Risitano, Antonio, Ilene C. Weitz, Carlos M. De Castro, Jean-Jacques Kiladjian, Morag Griffin, Hisakazu Nishimori, Mohamed Hamdani, Temitayo Ajayi, Scott B. Baver, and Regis Peffault de Latour. “Categorized hematologic response to pegcetacoplan versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria: post hoc analysis of data from a phase 3 randomized trial (PEGASUS).” In British Journal of Haematology, 193:24–25, 2021.

Scholars@Duke

Griffin, Morag, Peter Hillmen, Jeffrey Szer, Ilene C. Weitz, Alexander Roeth, Britta Hoechsmann, Jens Panse, et al. “Results of the Pegasus Phase 3 Randomized Trial Demonstrating Superiority of the C3 Inhibitor, Pegcetacoplan, Compared to Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria.” In British Journal of Haematology, 193:63–65, 2021.

Scholars@Duke

Sung, Anthony D., Shekeab Jauhari, Sharareh Siamakpour-Reihani, Arati V. Rao, Janet Staats, Cliburn Chan, Everett Meyer, et al. “Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.” Am J Hematol 95, no. 6 (June 2020): 662–71. https://doi.org/10.1002/ajh.25781.

PMID
32162718
Full Text

Hudson, Kathryn E., David Rizzieri, Samantha M. Thomas, Thomas W. LeBlanc, Zachary Powell, Louis Diehl, Joseph O. Moore, Carlos DeCastro, and Anne W. Beaven. “Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study.” Br J Haematol 184, no. 4 (February 2019): 647–50. https://doi.org/10.1111/bjh.15138.

PMID
29468651
Full Text

Heyman, Benjamin, David Rizzieri, David J. Adams, Carlos De Castro, Louis Diehl, Zhiguo Li, Joseph Moore, and Anne Beaven. “Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.” Clin Lymphoma Myeloma Leuk 18, no. 10 (October 2018): 679–86. https://doi.org/10.1016/j.clml.2018.07.285.

PMID
30166257
Full Text

Troy, Jesse D., Carlos M. de Castro, Mary Ruth Pupa, Greg P. Samsa, Amy P. Abernethy, and Thomas W. LeBlanc. “Patient-Reported Distress in Myelodysplastic Syndromes and Its Association With Clinical Outcomes: A Retrospective Cohort Study.” J Natl Compr Canc Netw 16, no. 3 (March 2018): 267–73. https://doi.org/10.6004/jnccn.2017.7048.

PMID
29523665
Full Text

Sung, Anthony D., Carlos M. de Castro, Thomas W. LeBlanc, Gwynn D. Long, Donna B. Adams, Danielle M. Brander, Sandeep Dave, et al. “Clinical Outcomes of Microtransplantation for Older Adults with Acute Myeloid Leukemia.” In Blood, Vol. 130. AMER SOC HEMATOLOGY, 2017.

Scholars@Duke

Pages